Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates.

Miller JW, King JB, Ryerson AB, Eheman CR, White MC.

AJR Am J Roentgenol. 2009 Feb;192(2):352-60. doi: 10.2214/AJR.08.1757.

PMID:
19155394
2.

Trends in breast cancer by race and ethnicity: update 2006.

Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

3.

Trends in breast cancer by race and ethnicity.

Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M.

CA Cancer J Clin. 2003 Nov-Dec;53(6):342-55. Erratum in: CA Cancer J Clin. 2004 May-Jun;54(3):181.

4.

Effect of three decades of screening mammography on breast-cancer incidence.

Bleyer A, Welch HG.

N Engl J Med. 2012 Nov 22;367(21):1998-2005. doi: 10.1056/NEJMoa1206809.

5.

Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.

Henley SJ, King JB, German RR, Richardson LC, Plescia M; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2010 Nov 26;59(9):1-25.

6.

Incidence of and treatment for ductal carcinoma in situ of the breast.

Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C.

JAMA. 1996 Mar 27;275(12):913-8.

PMID:
8598618
7.

Secular trends in the incidence of female breast cancer in the United States, 1973-1998.

Nasseri K.

Breast J. 2004 Mar-Apr;10(2):129-35. Erratum in: Breast J. 2004 Jul-Aug;10(4):380.

PMID:
15009040
8.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
9.
10.
11.

Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.

Helvie MA, Chang JT, Hendrick RE, Banerjee M.

Cancer. 2014 Sep 1;120(17):2649-56. doi: 10.1002/cncr.28784. Epub 2014 May 19. Erratum in: Cancer. 2014 Nov 1;120(21):3426.

12.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

13.

Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1571-9.

PMID:
8901855
14.

Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).

Anderson WF, Jatoi I, Devesa SS.

Breast Cancer Res Treat. 2006 Oct;99(3):333-40. Epub 2006 May 9.

PMID:
16703451
15.
16.

Socioeconomic disparities in the decline in invasive breast cancer incidence.

Sprague BL, Trentham-Dietz A, Burnside ES.

Breast Cancer Res Treat. 2010 Aug;122(3):873-8. doi: 10.1007/s10549-010-0737-y. Epub 2010 Jan 20.

17.

Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis.

Randolph WM, Goodwin JS, Mahnken JD, Freeman JL.

Ann Intern Med. 2002 Nov 19;137(10):783-90.

PMID:
12435214
18.

Prospective breast cancer risk prediction model for women undergoing screening mammography.

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

PMID:
16954473
19.

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.

DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A.

CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29.

20.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

PMID:
17652280

Supplemental Content

Support Center